Ultragenyx Pharmaceutical
RARE
#4542
Rank
HK$18.19 B
Marketcap
HK$184.77
Share price
-2.48%
Change (1 day)
-34.72%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: HK$18.19 Billion

As of May 2026 Ultragenyx Pharmaceutical has a market cap of HK$18.19 Billion. This makes Ultragenyx Pharmaceutical the world's 4542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$18.19 B-29.09%
2025HK$25.66 B-17.55%
2024HK$31.12 B1.5%
2023HK$30.66 B20.85%
2022HK$25.37 B-43.22%
2021HK$44.69 B-37.05%
2020HK$70.99 B269.02%
2019HK$19.23 B11.09%
2018HK$17.31 B12.21%
2017HK$15.43 B-30.73%
2016HK$22.27 B-34.1%
2015HK$33.80 B211.04%
2014HK$10.86 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

HK$18.66 Billion
by Nasdaq info icon info icon
HK$18.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
HK$7.08 B-61.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$6.31 B-65.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.63 B 95.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$75.38 B 314.24%๐Ÿ‡บ๐Ÿ‡ธ USA